Exhibit 31.1
                                  ------------


                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                        PURSUANT TO RULE 13a-14(a) OF THE
                   SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, John Y. Yoon, certify that:

1.       I have reviewed  this annual report on Form 10-KSB of Paradigm  Medical
         Industries, Inc.;

2.       Based on my  knowledge,  this annual report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances  under which
         such  statements  were made, not misleading  with respect to the period
         covered by this annual report;

3.       Based on my knowledge,  the financial  statements,  and other financial
         information  included  in this  annual  report,  fairly  present in all
         material  respects the financial  condition,  results of operations and
         cash flows of the  registrant as of, and for, the periods  presented in
         this annual report;

4.       The registrant's  other  certifying  officers and I are responsible for
         establishing  and  maintaining  disclosure  controls and procedures (as
         defined  in  Exchange  Act  Rules  13a-15(e)  and  15d-15(e))  for  the
         registrant and have:

              (a) Designed such disclosure  controls and  procedures,  or caused
              such  disclosure  controls and procedures to be designed under our
              supervision,  to ensure that material  information relating to the
              registrant, including its consolidated subsidiaries, is made known
              to us by others  within those  entities,  particularly  during the
              period in which this annual report is being prepared;

              (b) Evaluated the  effectiveness  of the  registrant's  disclosure
              controls and  procedures  and  presented in this annual report our
              conclusions about the effectiveness of the disclosure controls and
              procedures,  as of the end of the period  covered  by this  annual
              report based on such evaluation; and

              (c) Disclosed in this annual report any change in the registrant's
              internal  control over financial  reporting  that occurred  during
              registrant's most recent fiscal quarter (the  registrant's  fourth
              fiscal  quarter  in  the  case  of  an  annual  report)  that  has
              materially affected, or is reasonably likely to materially affect,
              registration's internal control over financial reporting; and

5.       The registrant's other certifying officers and I have disclosed,  based
         on our most  recent  evaluation  of  internal  control  over  financial
         reporting,  to the  registrant's  auditors  and the audit  committee of
         registrant's  board of directors (or persons  performing the equivalent
         functions):

              (a) All significant  deficiencies  and material  weaknesses in the
              design or operation of internal  control over financial  reporting
              which are reasonably  likely to adversely  affect the registrant's
              ability  to  record,  process,   summarize  and  report  financial
              information; and

              (b) Any fraud,  whether or not material,  that involves management
              or other employees who have a significant role in the registrant's
              internal control over financial reporting.


Date: November 4, 2004

                                           /s/ John Y. Yoon
                                          -------------------------------------
                                          John Y. Yoon
                                          President and Chief Executive Officer